David J. Muzina, MD Director, Adult Inpatient Psychiatry; Director, Bipolar and Schizophrenia Clinics, Department of Psychiatry and Psychology, The Cleveland Clinic Foundation
Address: David J. Muzina, MD, Department of Psychiatry and Psychology, P57, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail muzinad@ccf.org
The author has indicated that he has received grant or research support from the AstraZenica and Eli Lilly corporations and is on the speaker's bureaus of the Pfizer, Eli Lilly, and Forest Pharmaceuticals corporations.
This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTMany people who attempt suicide or succeed at it visit their physicians shortly before the act; thus, primary care physicians have a key role in preventing suicide. The first step is to suspect that the patient might be at risk, and the second step is to ask about it. Nevertheless, one cannot predict whether any particular person will or will not attempt suicide.
